Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB known ✓ | P10828 | 1/20 | 0.42 |
| ▸ | CA1 known ✓ | P00915 | 3/20 | 0.32 |
| ▸ | CA2 known ✓ | P00918 | 2/20 | 0.32 |
| ▸ | CA4 known ✓ | P22748 | 2/20 | 0.32 |
| ▸ | MMP1 | P03956 | 2/20 | 0.32 |
| ▸ | MMP2 | P08253 | 2/20 | 0.32 |
| ▸ | MMP9 | P14780 | 2/20 | 0.32 |
| ▸ | MMP8 | P22894 | 2/20 | 0.32 |
| ▸ | MMP13 | P45452 | 2/20 | 0.32 |
| ▸ | CASP1 | P29466 | 1/20 | 0.32 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Silver SCHEMBL623539 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| Potassium Ion SCHEMBL6269201 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| SCHEMBL4576505 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| SCHEMBL4580568 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| SCHEMBL22598032 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| Zinc Ion SCHEMBL4582401 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| SCHEMBL10694663 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| SCHEMBL19179127 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| Lithium Ion SCHEMBL21069099 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| SCHEMBL28573082 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119612707-A | Method for degrading organic matters by electrochemical lithium extraction coupling electrooxidation of water produced by oil and gas field | 中国石油大学(北京) | 2025-03-14 | — | — | CN | claimed |
| CN-113998704-A | Silica nanoparticles, method for the production thereof, use thereof, composite and use thereof | 上海唯可生物科技有限公司 | 2022-02-01 | — | — | CN | claimed |
| CN-113787802-A | PET (polyethylene terephthalate) film for solar cell back panel and preparation method thereof | 宁波勤邦新材料科技有限公司 | 2021-12-14 | — | — | CN | claimed |
| US-9200118-B2 | Quaternised polybenzimidazole | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2015-12-01 | — | — | US | claimed |
| EP-2616499-B1 | QUATERNISED POLYBENZIMIDAZOLE | COUNCIL SCIENT IND RES (IN) | 2015-03-11 | — | — | EP | claimed |
| EP-2616499-A1 | QUATERNISED POLYBENZIMIDAZOLE | Council of Scientific & Industrial Research (IN) | 2013-07-24 | — | — | EP | claimed |
| US-20130184412-A1 | QUATERNISED POLYBENZIMIDAZOLE | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2013-07-18 | — | — | US | claimed |
| WO-2012035556-A1 | QUATERNISED POLYBENZIMIDAZOLE | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2012-03-22 | — | — | WO | claimed |
| US-20080312339-A1 | FLUORINE-SUBSTITUTED ALKYL PHENOL COMPOUNDS AND THEIR USES | BAKER MAX T | 2008-12-18 | — | — | US | claimed |
| US-20030194378-A1 | Novel aerosol formulation containing a polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-10-16 | — | — | US | claimed |
| WO-2003077894-A1 | FLUORINE-SUBSTITUTED ALKYL PHENOL COMPOUNDS AND THEIR USES | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2003-09-25 | — | — | WO | claimed |
| US-20030176513-A1 | Fluorine-substituted alkyl phenol compounds and their uses | IOWA RESEARCH FOUNDATION, UNIVERSITY OF | 2003-09-18 | — | — | US | claimed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | claimed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | claimed |
| WO-2026102095-A1 | METHODS FOR DETECTING PER- OR POLY-FLUOROALKYL SUBSTANCES WITH FLUOROPHORES | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2026-05-15 | — | — | WO | disclosed |
| EP-4657572-A1 | COMPOSITION, ELECTROCHEMICAL DEVICE BINDER, ELECTRODE MIXTURE, ELECTRODE, AND SECONDARY BATTERY | Daikin Industries, Ltd. (JP) | 2025-12-03 | — | — | EP | disclosed |
| US-20250349897-A1 | ELECTROLYTIC SOLUTION, AND ELECTROCHEMICAL DEVICE AND SECONDARY BATTERY USING SAME | DAIKIN INDUSTRIES, LTD. (JP) | 2025-11-13 | — | — | US | disclosed |
| US-4562275-A | ANTICARCINOGENIC AGENTS | BRISTOL-MYERS CO. (US) | 1985-12-31 | — | — | US | disclosed |
| US-4010212-A | REFRIGERANTS, SOLVENTS, DIELECTRIC OR INSULATING FLUIDS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1977-03-01 | — | — | US | disclosed |
| US-3981928-A | Perfluorotertiaryalkyl ethers | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1976-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030176513-A1 | Fluorine-substituted alkyl phenol compounds and their uses | AFF4, AFF1, AFF2 | THRB 3491/4885CA1 3712/4885CA2 2598/4885 |
| US-20080312339-A1 | FLUORINE-SUBSTITUTED ALKYL PHENOL COMPOUNDS AND THEIR USES | AFF4, AFF1, AFF2 | THRB 3491/4885CA1 3712/4885CA2 2598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.